Healthcare >> CEO Interviews >> October 12, 2001
H. JOSEPH REISER, Ph.D. President, Chief Executive Officer and Director,
joined Locus in January 2003. Previously, Dr. Reiser served as
President, Chief Executive Officer at Cytogen Corporation from 1998 to
2002 and is currently a member of the board of directors. Prior to
Cytogen, Dr. Reiser was Corporate Vice President and General Manager,
Pharmaceuticals and a member of the board of directors for Berlex
Laboratories, Inc., the U.S. subsidiary of Schering AG. During his 17
year tenure at Berlex, Dr. Reiser also held other positions of
increasing responsibility, serving as the first President of Schering
Berlin's Venture Corporation, Vice President, Technology and Industry
Relations, and Vice President, Drug Development and Technology. Dr.
Reiser also served on the boards of Endeavor Pharmaceuticals and
Personal Health Technologies Inc. and as Chairman of the New Jersey
Biotechnology Council from 2001-2002. Dr. Reiser received his Ph.D. in
Physiology from Indiana University School of Medicine, where he also
earned his Masters and Bachelor of Science degrees. Profile
of Cytogen Corporation?
Dr. Reiser: Cytogen Corporation is a biopharmaceutical company with an
established and growing
